Natural killer cell subsets and natural killer–like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features-Reference-Cited by-同舟云学术

Natural killer cell subsets and natural killer–like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features

Published:2011-05 Issue:5 Volume:42 Page:679-687
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Gibson Sarah E.,Swerdlow Steven H.,Felgar Raymond E.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. The microenvironment in mature B-cell malignancies: a target for new treatment strategies;Burger;Blood,2009

2. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo;Reddy;Br J Haematol,2008

3. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma;Glas;J Clin Oncol,2007

4. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL);Farinha;Blood,2005

5. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone;Taskinen;Clin Cancer Res,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory TR3-56 Cells in the Complex Panorama of Immune Activation and Regulation;Cells;2023-12-15

2. Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy;Expert Review of Anticancer Therapy;2023-06-27

3. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients;Viral Immunology;2023-05-01

4. Could immune cells be associated with nephropathy in Fabry disease patients?;International Urology and Nephrology;2023-01-20

5. The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies;Frontiers in Immunology;2021-09-07